Patients with COVID-19 present a wide spectrum of disease severity, from asymptomatic
cases in the majority to serious disease leading to critical care and even death. Clinically …

The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world.
The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Abstract Purpose of Review To review current literature on endothelial dysfunction with
previous coronaviruses, and present available data on the role of endothelial dysfunction in …

The pandemic of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has
become a global challenge to public health. While its typical clinical manifestations are …

The COVID-19 pandemic is an unprecedented healthcare emergency causing mortality and
illness across the world. Although primarily affecting the lungs, the SARS-CoV-2 virus also …

COVID-19 is an evolving systemic inflammatory pandemic disease, predominantly affecting
the respiratory system. Associated cardiovascular comorbid conditions result in severe to …

Background Obesity has emerged as a risk factor for severe coronavirus disease 2019
(COVID-19) infection. To inform treatment considerations the relationship between obesity …

Background: Endothelial dysfunction has a role in acute COVID-19, contributing to systemic
inflammatory syndrome, acute respiratory distress syndrome, and vascular events. Evidence …

Background Persistent symptoms including breathlessness, fatigue, and decreased exercise
tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological …

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection is associated,
alongside with lung infection and respiratory disease, to cardiovascular dysfunction that …